AMN — AMN Healthcare Services Inc stock price and chart

AMN

$41.62+2.77%

as of close, Oct 20, 2026

☾ AH $41.62 +2.77%

AMN Healthcare Services IncStock · HealthcareRussell 2000 · 0.04% of IWMUS Stock Market · 0.002% of VTIRussell 3000 · 0.002% of IWV

PeersMRNALLYMDTUNHJNJTMO

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEEEEEEEEE

20162019202120242026

20.030.040.050.060.070.080.090.0100.0110.0120.0010.0M$41.62

2026-10-20

Price$41.62

MA20$33.40

MA50$24.70

Vol5.0M

What would $1,000 invested in AMN be worth today? →

AMN returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $41.62
YTD price return: +164.09%
YTD total return: +164.09%
Next earnings: Nov 5, 2026 · After close
Market cap: 1.6B2016-12 1.8B2026-10 1.6B-12.8% over the window
Enterprise value: 2.1B
Shares outstanding: 38.7M2016-06 48M2026-06 38.7M-19.4% over the window
52W low: $14.97
52W high: $41.83
From 52W high: -0.50%
From 52W low: +178.02%
52W range: 99%

Volume

Rel volume: 0.93×
30D volume: 735.9K
30D $ vol: 26.8M

Fundamentals

Sales (ttm): 3.4B2016-06 1.7B2026-06 3.4B+98.8% over the window
Sales/share: $88.672016-06 $35.952026-06 $88.67+146.7% over the window
EPS (ttm): $2.692016-06 $2.162026-06 $2.69+24.3% over the window
FCF (ttm): 439.1M2016-06 52.6M2026-06 439.1M+734.7% over the window
FCF/share: $11.342016-06 $1.092026-06 $11.34+935.6% over the window
Book value/share: $19.142016-06 $8.392026-06 $19.14+128.3% over the window
Net margin: 3.05%2016-06 6.1%2026-06 3.1%-50.2% over the window
ROE: 14.15%2016-06 26.3%2026-06 14.2%-46.2% over the window
ROA: 4.44%2016-06 9.0%2026-06 4.4%-50.6% over the window
Debt / equity: 1.03×2015-12 0.522025-12 1.19+129.6% over the window
Current ratio: 1.132016-06 1.472026-06 1.13-23.1% over the window

Growth (CAGR, ttm) · 10Y

Sales: +24.00%2025-06-30 → 2026-06-302.8B → 3.4B (+24.0% total)-7.80%2023-06-30 → 2026-06-304.4B → 3.4B (-21.6% total)+3.25%2021-06-30 → 2026-06-302.9B → 3.4B (+17.4% total)+7.12%2016-06-30 → 2026-06-301.7B → 3.4B (+98.8% total)
Net income: n/a-30.99%2023-06-30 → 2026-06-30319.3M → 104.9M (-67.1% total)-9.47%2021-06-30 → 2026-06-30172.5M → 104.9M (-39.2% total)-0.10%2016-06-30 → 2026-06-30106M → 104.9M (-1.0% total)
FCF: +71.95%2025-06-30 → 2026-06-30255.5M → 439.1M (+71.9% total)+4.83%2023-06-30 → 2026-06-30381.2M → 439.1M (+15.2% total)+8.05%2021-06-30 → 2026-06-30298.1M → 439.1M (+47.3% total)+23.64%2016-06-30 → 2026-06-3052.6M → 439.1M (+734.7% total)
Shares: +1.06%2025-06-30 → 2026-06-3038.3M → 38.7M (+1.1% total)+0.65%2023-06-30 → 2026-06-3038M → 38.7M (+2.0% total)-3.90%2021-06-30 → 2026-06-3047.3M → 38.7M (-18.1% total)-2.13%2016-06-30 → 2026-06-3048M → 38.7M (-19.4% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: n/a-29.24%2023-06-30 → 2026-06-30$7.58 → $2.69 (-64.6% total)-5.69%2021-06-30 → 2026-06-30$3.60 → $2.69 (-25.4% total)+2.20%2016-06-30 → 2026-06-30$2.16 → $2.69 (+24.3% total)
Sales/share: +22.70%2025-06-30 → 2026-06-30$72.28 → $88.67 (+22.7% total)-8.39%2023-06-30 → 2026-06-30$115.34 → $88.67 (-23.1% total)+7.45%2021-06-30 → 2026-06-30$61.92 → $88.67 (+43.2% total)+9.45%2016-06-30 → 2026-06-30$35.95 → $88.67 (+146.7% total)
FCF/share: +70.14%2025-06-30 → 2026-06-30$6.67 → $11.34 (+70.1% total)+4.15%2023-06-30 → 2026-06-30$10.03 → $11.34 (+13.0% total)+12.44%2021-06-30 → 2026-06-30$6.31 → $11.34 (+79.7% total)+26.34%2016-06-30 → 2026-06-30$1.09 → $11.34 (+935.6% total)
Book value/share: +20.74%2025-06-30 → 2026-06-30$15.85 → $19.14 (+20.7% total)-1.74%2023-06-30 → 2026-06-30$20.17 → $19.14 (-5.1% total)-1.31%2021-06-30 → 2026-06-30$20.45 → $19.14 (-6.4% total)+8.60%2016-06-30 → 2026-06-30$8.39 → $19.14 (+128.3% total)
Price: +109.67%2025-10-20 → 2026-10-20$19.86 → $41.62 (+109.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-17.36%2023-10-20 → 2026-10-20$73.75 → $41.62 (-43.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-15.12%2021-10-20 → 2026-10-20$94.48 → $41.62 (-55.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+2.01%2016-10-19 → 2026-10-20$34.12 → $41.62 (+22.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +109.67%2025-10-20 → 2026-10-20$19.86 → $41.62 (+109.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-17.36%2023-10-20 → 2026-10-20$73.75 → $41.62 (-43.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-15.12%2021-10-20 → 2026-10-20$94.48 → $41.62 (-55.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+2.01%2016-10-19 → 2026-10-20$34.12 → $41.62 (+22.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 15.5×2016-12 18.542026-10 15.36-17.1% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 8.1×2016-12 10.372026-10 8.07-22.2% over the window
Fwd P/E: 44.3×
P/S (ttm)Market cap ÷ TTM revenue.: 0.5×2016-12 1.022026-10 0.47-53.8% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 2.2×2016-12 4.272026-10 2.17-49.0% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 3.7×2016-12 29.852026-10 3.67-87.7% over the window
EV/EBITDA (fy): 5.9×
EV/Sales (ttm): 0.6×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 27.24%2016-09 3.4%2026-06 35.0%+945.4% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 38.7M ÷ 38.3M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -1.06%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-1.06%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($792.2M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -1.06%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($2.3M) ÷ today's market cap ($1.6B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.14%2016-09 0.0%2026-06 0.2%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $2.3M + TTM dividends $0) ÷ today's market cap ($1.6B). Same caveat as the cash buyback yield.: 0.14%2016-09 0.0%2026-06 0.2%

Vs own 10Y history

P/E: 34th
P/OI: 26th
P/S: 19th
P/B: 22nd
P/FCF: 16th

Bar = where today’s multiple sits in AMN’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+2.77%

+13.90%

+21.48%

+23.28%

YTD

+164.09%

+109.57%

-55.95%

Financial statements

Open full AMN financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

AMN — AMN Healthcare Services Inc price, chart and key statistics